Forecast & Rating4 analysts currently cover Adma Biologics, of which 3 give a positive rating. The average price target is $17.00, about 73.3% upside from the current price of $9.81. Coverage is limited, so the data is for reference only. Data as of Sep 10, 2026; this does not constitute investment advice.
Sep 10, 2026Price forecast
$17.0073.29%
Forecast & RatingBuy
4analysts
- Strong buy50.00%
- Buy25.00%
- Hold25.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 21, 2026
Forecast met49.8%
Stock price$9.81
Avg. target$25.7
High target$30
Low target$17
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.